Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.42 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.39 |
| ▸ | IL1B | P01584 | 1/20 | 0.39 |
| ▸ | GABRP | O00591 | 4/20 | 0.39 |
| ▸ | GABRD | O14764 | 4/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 4/20 | 0.39 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5220202 | 0.87 | GABRB3 (0.42) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL4033423 | 0.82 | GABRB3 (0.40) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL4855148 | 0.80 | GABRP (0.41) | RAB9ANPC1MEN1KMT2APPARG | |
| Pyriprole SCHEMBL29422238 | 0.80 | GABRP (0.41) | RAB9ANPC1MEN1KMT2APPARG | |
| Pyriprole SCHEMBL27011 | 0.80 | GABRP (0.41) | RAB9ANPC1MEN1KMT2APPARG | |
| SCHEMBL14208660 | 0.78 | GABRP (0.39) | RAB9ANPC1MEN1KMT2APPARG | |
| SCHEMBL14208642 | 0.78 | GABRP (0.39) | RAB9ANPC1MEN1KMT2APPARG | |
| SCHEMBL1750983 | 0.73 | GABRP (0.39) | RAB9ANPC1MEN1KMT2APPARG | |
| SCHEMBL28073555 | 0.73 | GABRB3 (0.46) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Pyriprole SCHEMBL19032727 | 0.72 | GABRP (0.35) | RAB9ANPC1MEN1KMT2APPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7371768-B2 | Pyrazol derivatives, pest control agent comprising the same as active ingredient, and process for producing the same | NIHON NOHYAKU CO., LTD. (JP) | 2008-05-13 | — | — | US | disclosed |
| US-7371768-B2 | Pyrazol derivatives, pest control agent comprising the same as active ingredient, and process for producing the same | NIHON NOHYAKU CO., LTD. (JP) | 2008-05-13 | — | — | US | disclosed |
| EP-1310497-B1 | PYRAZOLE DERIVATIVE, PEST CONTROL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT AND PROCESS FOR PRODUCING THE SAME | NIHON NOHYAKU CO LTD (JP) | 2006-03-01 | — | — | EP | disclosed |
| US-20040053969-A1 | Pyrazol derivatives, pest control agent comprising the same as active ingredient, and process for producing the same | NIHON NOHYAKU CO., LTD. (JP) | 2004-03-18 | — | — | US | disclosed |
| EP-1310497-A1 | PYRAZOLE DERIVATIVES, PEST CONTROLLERS CONTAINING THE SAME AS THE ACTIVE INGREDIENT AND PROCESS FOR THEIR PRODUCTION | Nihon Nohyaku Co., Ltd. (JP) | 2003-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040053969-A1 | Pyrazol derivatives, pest control agent comprising the same as active ingredient, and process for producing the same | CTRL, AADAC, CBR3 | RAB9A 1148/4885NPC1 2012/4885MEN1 4636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.